search
Back to results

Integrated Exercise Program in Opioid Agonist Therapy Clinics (BAReAktiv)

Primary Purpose

Substance-Related Disorders

Status
Active
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Exercise intervention
Sponsored by
Haukeland University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Substance-Related Disorders focused on measuring Opiate substitution Treatment, Exercise Therapy, Exercise, Substance-Related Disorders

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Receiving OAT from an included outpatient clinic with follow-up weekly
  • Low level of physical activity measured using IPAQ (assessed at screening)
  • Confirming interest in participating in physical activity intervention and providing informed consent (criteria specified)
  • Giving informed consent

Exclusion Criteria:

  • Not able to participate in the intervention due to physical disabilities or severe mental disorders
  • Being imprisoned or in inpatient treatment settings

Sites / Locations

  • LAR Helse Stavanger HF
  • Department of Addiction Medicine, Haukeland University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Exercise intervention

Standard

Arm Description

The intervention is a supervised group-based exercise intervention for 16 weeks, including two outdoor sessions per week. The workout consists of two parts, endurance and a strength training segment. Every workout follows the same structure and lasts approximately 45 minutes. The exercise starts with roughly 15 minutes of endurance warm-up. After the warm-up follows the interval with eight repetitions of 30 seconds uphill, and the participants can freely choose between walking or running. The desired intensity of the intervals is >13 on Borg-score 20. The session will end with four specific exercises focusing on strength training of large muscle groups, including mm. pectoralis major, rectus abdominis, quadriceps femoris, gluteus maximus and latissimus dorsi. The strength training program follows the same structure as the intervals. Clinical staff, research staff, and people with user experience will supervise the exercise sessions.

Participants randomised to standard treatment will receive regular OAT clinic follow-up without added supplementation.

Outcomes

Primary Outcome Measures

Psychological distress
The primary outcome is psychological distress assessed with the Norwegian validated translation ten item version of Hopkins Symptom Checklist (SCL-10) in the mid of the intervention period 16 weeks after initiation (12-20). This will be evaluated with mean SCL-10 item score and compared between intervention and control arm.

Secondary Outcome Measures

Physical functioning
Physical functioning assessed with 4-minutes step-test measuring numbers of steps climbed in period
Physical functioning
Physical functioning assessed using the Norwegian validated translation of the International physical activity questionnaire (IPAQ).
Fatigue Symptom Scale
Changes in fatigue will be assessed with the Fatigue Symptom Scale (FSS-3, 0-18, higher is worse)
Biochemical indicator of inflammation
Biochemical indicators of inflammation measured with C-reactive protein in serum
Health-related quality of life
Changes in quality of life will be assessed with EuroQoL five dimensions (EQ-5D-5L, 0-100, higher is better)

Full Information

First Posted
February 7, 2022
Last Updated
October 16, 2023
Sponsor
Haukeland University Hospital
Collaborators
Helse Stavanger HF, Helse Vest, University of Bergen
search

1. Study Identification

Unique Protocol Identification Number
NCT05242848
Brief Title
Integrated Exercise Program in Opioid Agonist Therapy Clinics
Acronym
BAReAktiv
Official Title
Integrated Exercise in Opioid Agonist Therapy Clinics: A Randomised Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
April 7, 2022 (Actual)
Primary Completion Date
October 2023 (Anticipated)
Study Completion Date
December 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Haukeland University Hospital
Collaborators
Helse Stavanger HF, Helse Vest, University of Bergen

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Background: Drug use is associated with unhealthy lifestyle choices, resulting in adverse social and health consequences. Particular people with opioid dependence have high morbidity and reduced quality of life. A reduction in fitness level for people with substance use disorder reduces the general health and quality of life. Physical activity is recommended as an adjunctive treatment for people with substance use disorder. Due to its positive effects on health, quality of life and substance use. There is minimal evidence from well-controlled randomised trials among people receiving opioid agonist therapy. However, studies indicate that exercise could be promising in opioid agonist therapy. Study design: BAReAktiv is a multicentre randomised controlled trial. The study aims to recruit approximately 225 patients receiving opioid agonist therapy. Intervention: A 16-week group-based exercise intervention with workouts twice a week. The exercise program will consist of endurance and strength training. The intervention will be integrated into outpatient's clinics in Bergen and Stavanger, Norway. Study population: The target group will be patients over 18 years of age with severe opioid use disorder receiving OAT in outpatient clinics. Expected outcome: This study will inform the relative advantages and disadvantages of an integrated exercise program as an adjunctive treatment. Both physical and mental health outcomes are of interest. Further scale-up will be considered if the provided exercise program is safe and effective.
Detailed Description
See below each section

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Substance-Related Disorders
Keywords
Opiate substitution Treatment, Exercise Therapy, Exercise, Substance-Related Disorders

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The intervention is a supervised group-based exercise intervention for 16 weeks, including two outdoor sessions per week. The workout consists of two parts, endurance and a strength training segment. Every workout follows the same structure and lasts approximately 45 minutes. The exercise starts with roughly 15 minutes of endurance warm-up. After the warm-up follows the interval with eight repetitions of 30 seconds uphill, and the participants can freely choose between walking or running. The desired intensity of the intervals is >13 on Borg-score 20. The session will end with four specific exercises focusing on strength training of large muscle groups, including mm. pectoralis major, rectus abdominis, quadriceps femoris, gluteus maximus and latissimus dorsi. The strength training program follows the same structure as the intervals. Clinical staff, research staff, and people with user experience will supervise the exercise sessions.
Masking
Outcomes Assessor
Masking Description
Blinding is regarded as difficult and infeasible. Patients will be informed of the follow-up they will receive, but not on other follow-up alternatives that are used or the exact hypotheses for the study. Outcomes assessor will be blinded.
Allocation
Randomized
Enrollment
324 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Exercise intervention
Arm Type
Experimental
Arm Description
The intervention is a supervised group-based exercise intervention for 16 weeks, including two outdoor sessions per week. The workout consists of two parts, endurance and a strength training segment. Every workout follows the same structure and lasts approximately 45 minutes. The exercise starts with roughly 15 minutes of endurance warm-up. After the warm-up follows the interval with eight repetitions of 30 seconds uphill, and the participants can freely choose between walking or running. The desired intensity of the intervals is >13 on Borg-score 20. The session will end with four specific exercises focusing on strength training of large muscle groups, including mm. pectoralis major, rectus abdominis, quadriceps femoris, gluteus maximus and latissimus dorsi. The strength training program follows the same structure as the intervals. Clinical staff, research staff, and people with user experience will supervise the exercise sessions.
Arm Title
Standard
Arm Type
No Intervention
Arm Description
Participants randomised to standard treatment will receive regular OAT clinic follow-up without added supplementation.
Intervention Type
Behavioral
Intervention Name(s)
Exercise intervention
Intervention Description
The intervention is a supervised group-based exercise intervention for 16 weeks, including two outdoor sessions per week. The workout consists of two parts, endurance and a strength training segment. Every workout follows the same structure and lasts approximately 45 minutes. The exercise starts with roughly 15 minutes of endurance warm-up. After the warm-up follows the interval with eight repetitions of 30 seconds uphill, and the participants can freely choose between walking or running. The desired intensity of the intervals is >13 on Borg-score 20. The session will end with four specific exercises focusing on strength training of large muscle groups, including mm. pectoralis major, rectus abdominis, quadriceps femoris, gluteus maximus and latissimus dorsi. The strength training program follows the same structure as the intervals. Clinical staff, research staff, and people with user experience will supervise the exercise sessions.
Primary Outcome Measure Information:
Title
Psychological distress
Description
The primary outcome is psychological distress assessed with the Norwegian validated translation ten item version of Hopkins Symptom Checklist (SCL-10) in the mid of the intervention period 16 weeks after initiation (12-20). This will be evaluated with mean SCL-10 item score and compared between intervention and control arm.
Time Frame
Mid of the intervention period 16 weeks after initiation
Secondary Outcome Measure Information:
Title
Physical functioning
Description
Physical functioning assessed with 4-minutes step-test measuring numbers of steps climbed in period
Time Frame
Mid of the intervention period 16 weeks after initiation
Title
Physical functioning
Description
Physical functioning assessed using the Norwegian validated translation of the International physical activity questionnaire (IPAQ).
Time Frame
Mid of the intervention period 16 weeks after initiation
Title
Fatigue Symptom Scale
Description
Changes in fatigue will be assessed with the Fatigue Symptom Scale (FSS-3, 0-18, higher is worse)
Time Frame
Mid of the intervention period 16 weeks after initiation
Title
Biochemical indicator of inflammation
Description
Biochemical indicators of inflammation measured with C-reactive protein in serum
Time Frame
Mid of the intervention period 16 weeks after initiation
Title
Health-related quality of life
Description
Changes in quality of life will be assessed with EuroQoL five dimensions (EQ-5D-5L, 0-100, higher is better)
Time Frame
Mid of the intervention period 16 weeks after initiation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Receiving OAT from an included outpatient clinic with follow-up weekly Low level of physical activity measured using IPAQ (assessed at screening) Confirming interest in participating in physical activity intervention and providing informed consent (criteria specified) Giving informed consent Exclusion Criteria: Not able to participate in the intervention due to physical disabilities or severe mental disorders Being imprisoned or in inpatient treatment settings
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lars T Fadnes, PHD
Organizational Affiliation
Haukeland University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
LAR Helse Stavanger HF
City
Stavanger
State/Province
Rogaland
ZIP/Postal Code
4010
Country
Norway
Facility Name
Department of Addiction Medicine, Haukeland University Hospital
City
Bergen
State/Province
Vestland
ZIP/Postal Code
5020
Country
Norway

12. IPD Sharing Statement

Plan to Share IPD
No
Links:
URL
https://helse-bergen.no/avdelinger/rusmedisin/rusmedisin-seksjon-forsking/bar/atlas4lar-kartlegging-og-behandling-av-lungesykdom-i-legemiddelassistert-behandling
Description
Related Info

Learn more about this trial

Integrated Exercise Program in Opioid Agonist Therapy Clinics

We'll reach out to this number within 24 hrs